Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Find out which credit card is best for traveling abroad to make your trips easier and more rewarding.
22,553 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
A hypothetical whistleblower raises questions about how government narratives can influence markets. This article exp...
Jefferies boosts Palo Alto Networks price target to $265 with a Buy rating as AI-driven threats compress attack timel...
A lithium-tech startup has reached unicorn status with a $1 billion valuation as demand for lithium accelerates acros...
Teva is shifting from a debt-laden generic player to a branded-focused pharma with a stronger balance sheet. This piv...
Strategy unveils a private repurchase of roughly $1.5 billion in convertible notes, funded by cash, ATM proceeds, and...
As Mink (INKT) closes 2025, investors want clarity on growth, margins, and cash generation. This analysis breaks down...
P3 Health is shaping the future of value-based care with its platform. This guide breaks down what to expect from hea...
Investors eye the long end of the curve as Kevin Warsh's QT stance shifts income dynamics. Forget utility dividends. ...
The 2-year Treasury yield climbs to 4.09%, tightening liquidity and weighing on Bitcoin’s breakout attempt. Here’s wh...
Warren Buffett's century-spanning Dow forecast remains a talking point as the index sits in the mid-30,000s in 2026. ...
The musician sheryl crow selling a 2.2-acre slice from her Nashville estate for $1.8 million highlights growing liqui...